The mark consists of the word "XIPERE" beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at the bottom of the letter "I" and continuing through the center of the letters "P", "E", and ending at the bottom of the letter "R" followed by a capital "E".
Mark For: XIPERE™ trademark registration is intended to cover the categories of
>Color is not claimed as a feature of the mark. The mark consists of the word "XIPERE" beginning with a capital "X" followed by the capital letter "I" with an arc-like line beginning at the bottom of the letter "I" and continuing through the center of the letters "P", "E", and ending at the bottom of the letter "R" followed by a capital "E".
Research | OneLook Acronym Finder |
Serial Number | 88221046 |
Mark Literal Elements | XIPERE |
Mark Drawing Type | 3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S)/NUMBER(S) |
Mark Type | TRADEMARK |
Standard Character Claim | No |
Register | PRINCIPAL |
Current Location | INTENT TO USE SECTION 2019-06-11 |
Basis | 1(b) |
Class Status | ACTIVE |
Primary US Classes |
|
Primary International Class |
|
Filed Use | No |
Current Use | No |
Intent To Use | Yes |
Filed ITU | Yes |
44D Filed | No |
44E Current | No |
66A Current | No |
Current Basis | No |
No Basis | No |
Attorney Name | Bassam N. Ibrahim |
Attorney Docket Number | 0080003-115 |
2018-12-07 | Application Filed |
2018-12-30 | Location: NEW APPLICATION PROCESSING |
2018-12-30 | Status: Live/Pending |
2019-01-04 | Transaction Date |
2019-04-16 | Published |
2019-04-16 | Published for Opposition |
2019-06-11 | Location: INTENT TO USE SECTION |
2020-12-10 | Status: A third request for extension of time to file a Statement of Use has been granted. |
Party: | Clearside Biomedical, Inc. |
Address | 900 North Point Parkway, Suite 200 Alpharetta, GEORGIA UNITED STATES 30005 |
Legal Entity Type | Corporation |
Legal Entity State | DELAWARE |
Drawing | JPEG | 2018-12-07 |
TEAS RF New Application | MULTI | 2018-12-07 |
Preliminary Amendment | MULTI | 2018-12-18 |
Amendment and Mail Process Complete | MULTI | 2018-12-21 |
Design Search Code Corr Project | XML | 2019-01-01 |
Notation to File | XML | 2019-03-08 |
XSearch Search Summary | APPLICATION/XML | 2019-03-08 |
Publication & Issue Review Complete | MULTI | 2019-03-13 |
TRAM Snapshot of App at Pub for Oppostn | MULTI | 2019-03-13 |
Notice of Publication | XML | 2019-03-27 |
Notification Of Notice of Publication | XML | 2019-03-27 |
OG Publication Confirmation | APPLICATION/XML | 2019-04-16 |
Notice of Allowance | APPLICATION/XML | 2019-06-11 |
Extension of Time to File SOU | APPLICATION/XML,IMAGE/JPEG | 2019-12-03 |
ITU Extension Approval | APPLICATION/XML | 2019-12-05 |
ITU Unit Action | MULTI | 2019-12-05 |
Extension of Time to File SOU | MULTI | 2020-04-24 |
ITU Extension Approval | APPLICATION/XML | 2020-04-28 |
ITU Unit Action | MULTI | 2020-04-28 |
Extension of Time to File SOU | APPLICATION/XML | 2020-12-10 |
ITU Extension Approval | APPLICATION/XML | 2020-12-12 |
ITU Unit Action | MULTI | 2020-12-12 |
261709 | Bands, curved; Bars, curved; Curved line(s), band(s) or bar(s); Lines, curved |
IC 005. US 006 018 044 046 051 052. G & S: Ocular pharmaceuticals; Ophthalmic preparations
IC 010. US 026 039 044. G & S: Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems
International Codes: | 5 |
U.S. Codes: | 006,018,044,046,051,052 |
International Codes: | 10 |
U.S. Codes: | 026,039,044 |
Type Code | Type |
---|---|
GS0101 | Medical devices, namely, a needle-based injection system for delivery of pharmaceuticals and injection needles; Ophthalmic medical devices, namely, a needle-based injection system for delivery of pharmaceuticals to eye tissue and injection needles; drug delivery systems |
Description | Date | Proceeding Number |
---|---|---|
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-12-12 | |
TEAS EXTENSION RECEIVED | 2020-12-10 | |
EXTENSION 3 GRANTED | 2020-12-10 | 98765 |
EXTENSION 3 FILED | 2020-12-10 | 98765 |
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY | 2020-08-12 | |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2020-04-28 | |
TEAS EXTENSION RECEIVED | 2020-04-24 | |
EXTENSION 2 GRANTED | 2020-04-24 | 98765 |
EXTENSION 2 FILED | 2020-04-24 | 98765 |
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED | 2019-12-05 | |
TEAS EXTENSION RECEIVED | 2019-12-03 | |
EXTENSION 1 GRANTED | 2019-12-03 | 98765 |
EXTENSION 1 FILED | 2019-12-03 | 98765 |
NOA E-MAILED - SOU REQUIRED FROM APPLICANT | 2019-06-11 | |
PUBLISHED FOR OPPOSITION | 2019-04-16 | |
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | 2019-04-16 | |
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | 2019-03-27 | |
LAW OFFICE PUBLICATION REVIEW COMPLETED | 2019-03-12 | 70633 |
APPROVED FOR PUB - PRINCIPAL REGISTER | 2019-03-12 | |
ASSIGNED TO EXAMINER | 2019-03-07 | 94050 |
NOTICE OF DESIGN SEARCH CODE E-MAILED | 2019-01-01 | |
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM | 2018-12-30 | |
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED | 2018-12-20 | 70633 |
ASSIGNED TO LIE | 2018-12-20 | 70633 |
TEAS VOLUNTARY AMENDMENT RECEIVED | 2018-12-18 | |
NEW APPLICATION ENTERED IN TRAM | 2018-12-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.